Literature DB >> 27768127

Fatigue Self-Management Behaviors in Patients With Advanced Cancer: A Prospective Longitudinal Survey.

Raymond Chan1, Patsy Yates2, Alexandra L McCarthy2.   

Abstract

PURPOSE/
OBJECTIVES: To explore the fatigue self-management behaviors and factors associated with effectiveness of these behaviors in patients with advanced cancer.
.
DESIGN: Prospective longitudinal interviewer-administered survey.
.
SETTING: Royal Brisbane and Women's Hospital in Queensland, Australia.
. SAMPLE: 152 outpatients with metastatic breast, lung, colorectal, and prostate cancer experiencing fatigue were recruited.
.
METHODS: Patients were surveyed on three occasions. MAIN RESEARCH VARIABLES: Fatigue self-management behavior (perceived effectiveness, self-efficacy, and frequency), medical and demographic characteristics (sites of primary cancer and metastasis, comorbidity, performance status), social support, depression, anxiety, and other symptoms were assessed.
.
FINDINGS: The participants reported moderate levels of fatigue at baseline and maintained moderate levels at four and eight weeks. On average, participants consistently used about nine behaviors at each time point. Factors significantly associated with higher levels of perceived effectiveness of fatigue self-management behaviors were higher self-efficacy, higher education level, and lower levels of depressive symptoms. 
.
CONCLUSIONS: The findings of this study demonstrate that patients with cancer, even those with advanced disease, still want and are able to use a number of behaviors to control their fatigue. Self-management interventions that aim to enhance self-efficacy and address any concurrent depressive symptoms have the potential to reduce fatigue severity.
. IMPLICATIONS FOR NURSING: Nurses are well positioned to play a key role in supporting patients in their fatigue self-management.

Entities:  

Keywords:  advanced cancer; cancer-related fatigue; fatigue; longitudinal survey
; metastatic disease; self-management behaviors

Mesh:

Year:  2016        PMID: 27768127     DOI: 10.1188/16.ONF.762-771

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  6 in total

1.  Self-management of patients with advanced cancer: A systematic review of experiences and attitudes.

Authors:  Sophie I van Dongen; Kim de Nooijer; Jane M Cramm; Anneke L Francke; Wendy H Oldenmenger; Ida J Korfage; Frederika E Witkamp; Rik Stoevelaar; Agnes van der Heide; Judith Ac Rietjens
Journal:  Palliat Med       Date:  2020-02       Impact factor: 4.762

2.  Reconstruction of feminine identity: the strategies of women with breast cancer to cope with body image altered.

Authors:  Sharareh Zeighami Mohammadi; Sima Mohammad Khan; Kermanshahi Zohreh Vanaki
Journal:  Int J Womens Health       Date:  2018-11-01

3.  Socioeconomic position and use of healthcare in the last year of life: A systematic review and meta-analysis.

Authors:  Joanna M Davies; Katherine E Sleeman; Javiera Leniz; Rebecca Wilson; Irene J Higginson; Julia Verne; Matthew Maddocks; Fliss E M Murtagh
Journal:  PLoS Med       Date:  2019-04-23       Impact factor: 11.069

4.  Factors in Cancer-Related Fatigue Self-Management Behaviors of Outpatients Undergoing Chemotherapy.

Authors:  Ikuko Chiba; Tomoyo Sasahara; Michiyo Mizuno
Journal:  Asia Pac J Oncol Nurs       Date:  2019 Jul-Sep

5.  Effects of Acceptance and Commitment Therapy on fatigue interference and health-related quality of life among patients with advanced lung cancer: A pilot randomized controlled trial.

Authors:  Huiyuan Li; Xiaohuan Jin; Marques Shek Nam Ng; Ka Fai Mann; Nina Wang; Cho Lee Wong
Journal:  Asia Pac J Oncol Nurs       Date:  2022-06-09

6.  Understanding fatigue in adults with visual impairment: A path analysis study of sociodemographic, psychological and health-related factors.

Authors:  Wouter Schakel; Christina Bode; Peter M van de Ven; Hilde P A van der Aa; Carel T J Hulshof; Gerardus H M B van Rens; Ruth M A van Nispen
Journal:  PLoS One       Date:  2019-10-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.